Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Viracta Therapeutics Inc VIRX

Healthcare Biotechnology
Viracta Therapeutics, Inc. is a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers, which impact patients worldwide. The Company’s lead product candidate is an all-oral combination therapy of its proprietary investigational drug, nanatinostat, and the antiviral agent valganciclovir (collectively, Nana-val). Nana-val is being evaluated... see more

Recent & Breaking News (NDAQ:VIRX)

Sunesis Pharmaceuticals Announces Presentation of Preliminary Data from Phase 1b/2 Trial of Vecabrutinib in Patients with CLL and Other B-Cell Malignancies at ASH Annual Meeting

GlobeNewswire December 2, 2018

Sunesis Pharmaceuticals to Provide Program Update for Non-Covalent BTK-Inhibitor Vecabrutinib at Analyst & Investor Event during ASH 2018

GlobeNewswire November 28, 2018

Sunesis Pharmaceuticals to Present at the 30th Annual Piper Jaffray Healthcare Conference

GlobeNewswire November 19, 2018

Report: Developing Opportunities within NeuroMetrix, Sunesis Pharmaceuticals, Siga Technologies, NexPoint Residential Trust, Frequency Electronics, and Horizon Technology Finance — Future Expectations, Projections Moving into 2018

GlobeNewswire November 15, 2018

Sunesis Pharmaceuticals Reports Third Quarter 2018 Financial Results and Recent Highlights

GlobeNewswire November 5, 2018

Sunesis Pharmaceuticals Announces Presentations at 60th American Society of Hematology Annual Meeting

GlobeNewswire November 1, 2018

Sunesis Pharmaceuticals to Host Conference Call on November 5th to Discuss Third Quarter 2018 Financial Results and Recent Highlights

GlobeNewswire October 29, 2018

Sunesis Pharmaceuticals to Present at the 2018 Cantor Global Healthcare Conference

GlobeNewswire September 26, 2018

Sunesis Pharmaceuticals to Present at the Wells Fargo Securities 2018 Healthcare Conference

GlobeNewswire August 30, 2018

Sunesis Pharmaceuticals Reports Second Quarter 2018 Financial Results and Recent Highlights

GlobeNewswire August 7, 2018

Sunesis Pharmaceuticals to Host Conference Call on August 7th to Discuss Second Quarter 2018 Financial Results and Recent Highlights

GlobeNewswire July 31, 2018

Sunesis Pharmaceuticals Strengthens Senior Management Team

GlobeNewswire July 9, 2018

Sunesis Pharmaceuticals Enters into $15.5 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC

GlobeNewswire June 25, 2018

Sunesis Pharmaceuticals Announces Presentations at the EHA Annual Meeting

GlobeNewswire June 18, 2018

Sunesis Pharmaceuticals Reports First Quarter 2018 Financial Results and Recent Highlights

GlobeNewswire May 8, 2018

Sunesis Pharmaceuticals to Host Conference Call on May 8th to Discuss First Quarter 2018 Financial Results and Recent Highlights

GlobeNewswire May 1, 2018

Sunesis Pharmaceuticals to Present at Upcoming Investor Conferences

GlobeNewswire March 14, 2018

Sunesis Pharmaceuticals Announces Cancellation of Presentation and Webcast at Cowen & Company 38th Annual Health Care Conference

GlobeNewswire March 13, 2018

44 Biggest Movers From Friday

Benzinga.com  March 12, 2018

Mid-Afternoon Market Update: Crude Oil Up Over 3%; PDL BioPharma Shares Spike Higher

Benzinga.com  March 9, 2018